Chemotherapy-Induced Nausea and Vomiting in Gastrointestinal Cancer Patients: Do We Need to Revisit Guidelines?

Purpose  The objective of this study was to assess the proportion of patients developing chemotherapy-induced nausea and vomiting (CINV) after receiving chemotherapy for gastrointestinal (GI) cancers, despite receiving antiemetic prophylaxis (AEP) as per the standard guidelines. Patients and Methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapoor, Akhil, Jain, Ashutosh, Sharma, Abhishek, Shah, Minit, Chinthala, Shravan, Nandhana, Ravindra, Bhargava, Prabhat, Ramaswamy, Anant, Srinivas, Sujay, Ostwal, Vikas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Private Ltd 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205558/
https://www.ncbi.nlm.nih.gov/pubmed/34141686
http://dx.doi.org/10.1055/s-0041-1729493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205558/
https://www.ncbi.nlm.nih.gov/pubmed/34141686
http://dx.doi.org/10.1055/s-0041-1729493

Ejemplares similares